Thema
Journal Article
13
Review
13
cardiovascular disease
4
cardiovascular disease (CVD)
4
Editorial
3
cardiovascular risk
3
ANGPTL3 inhibitors
2
Cholesterol, HDL
2
HDL functionality
2
PCSK9 inhibitors
2
cholesterol efflux capacity (CEC)
2
inclisiran
2
ApoA-I Milano
1
CVD
1
Cardiovascular disease
1
Cholesterol, LDL
1
Comment
1
Dyslipidemia
1
HDL-cholesterol (HDL-C)
1
Inflammation
1
LDL receptors
1
LDL-C-lowering
1
LDL-cholesterol
1
LXR agonists
1
Lipid-modifying therapies
1
Lipoproteins, HDL
1
Obesity
1
PPARβ/δ agonists
1
Spironolactone
1
aerobic exercise
1
alcohol
1
aldosterone
1
anti-inflammatory agents/therapy
1
apolipoprotein A-I (ApoA-I)
1
bempedoic acid
1
cardiometabolic effects
1
diabetes mellitus
1
dietary habits
1
evinacumab
1
familial hypercholesterolemia
1
genetic disorders
1
glycemic control
1
heart failure (HF)
1
heart failure with preserved ejection fraction (HFpEF)
1
high density lipoprotein (HDL)
1
hypercholesterolemia
1
hyperlipoproteinemia (a)
1
lipid-lowering
1
lipoprotein (a)
1
liraglutide
1
mehr ...